The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.
Investors understand that their principal will be at very high risk
Category
Sector Funds
Launch Date
30-Nov-18
ISIN Code
INF740KA1LD8
Scheme Benchmark
BSE HEALTH CARE - TRI
AUM ( in Cr.)
3,339.79
portfolio price to book value
7.8
investing style?
Mid Growth
fund manager?
Chirag Dagli
inception date (regular plan)
expense ratio (regular plan) %
1.90